These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1371724)

  • 21. Malignancy hypercalcemia: evaluation of parathyroid function and response to treatment.
    Mallette LE; Beck P; Vandepol C
    Am J Med Sci; 1991 Oct; 302(4):205-10. PubMed ID: 1928231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function.
    Gao P; Scheibel S; D'Amour P; John MR; Rao SD; Schmidt-Gayk H; Cantor TL
    J Bone Miner Res; 2001 Apr; 16(4):605-14. PubMed ID: 11315988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary hyperparathyroidism or hypercalcaemia of malignancy?
    Birkeland KI; Gallefoss F; Olsson S; Haug E
    Scand J Clin Lab Invest; 1992 Jun; 52(4):347-9. PubMed ID: 1439519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of intact parathyrin by immunoradiometric assay evaluated in normal children and in patients with various disorders of calcium metabolism.
    Saggese G; Baroncelli GI; Bertelloni S
    Clin Chem; 1991 Nov; 37(11):1999-2001. PubMed ID: 1934478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parathyroid hormone-related protein (PTH-rP)-associated hypercalcemia in a patient with an atypical chronic lymphocytic leukemia.
    Vlasveld LT; Pauwels P; Ermens AA; Aarnoudse WH; Ooms HW; Haak HR
    Neth J Med; 1999 Jan; 54(1):21-6. PubMed ID: 10048292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of an immunoradiometric assay of parathyrin-related protein in unextracted plasma.
    Ratcliffe WA; Norbury S; Heath DA; Ratcliffe JG
    Clin Chem; 1991 May; 37(5):678-85. PubMed ID: 2032320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypercalcemia associated with infantile fibrosarcoma producing parathyroid hormone-related protein.
    Michigami T; Yamato H; Mushiake S; Nakayama M; Yoneda A; Satomura K; Imura K; Ozono K
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1090-5. PubMed ID: 8772581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid hormone-related peptide and primary hyperparathyroidism.
    Testini M; Gurrado A; Lissidini G; Piccinni G; Greco L; Basile F; Biondi A
    Front Biosci (Schol Ed); 2010 Jan; 2(1):299-312. PubMed ID: 20036948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma.
    Ikeda K; Ohno H; Hane M; Yokoi H; Okada M; Honma T; Yamada A; Tatsumi Y; Tanaka T; Saitoh T
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1322-7. PubMed ID: 7962324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice.
    Guise TA; Chirgwin JM; Favarato G; Boyce BF; Mundy GR
    Lab Invest; 1992 Oct; 67(4):477-85. PubMed ID: 1434529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
    Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
    N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of parathyroid hormone-related protein in hypercalcemia of malignancy: comparison of midregional radioimmunoassay and two-site immunoradiometric assay.
    Blind E; Raue F; Meinel T; Bucher M; Manegold C; Ebert W; Vogt-Moykopf I; Ziegler R
    Clin Investig; 1993 Jan; 71(1):31-6. PubMed ID: 8453257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
    Wimalawansa SJ
    Cancer; 1994 Apr; 73(8):2223-30. PubMed ID: 8156530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoreactivity of plasma parathyrin-related peptide: three region-specific radioimmunoassays and a two-site immunoradiometric assay compared.
    Ratcliffe WA; Norbury S; Stott RA; Heath DA; Ratcliffe JG
    Clin Chem; 1991 Oct; 37(10 Pt 1):1781-7. PubMed ID: 1845254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
    Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
    Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of parathyroid hormone.
    Endres DB; Villanueva R; Sharp CF; Singer FR
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid-hormone-related peptide immunochemiluminometric assay. Developed with polyclonal antisera produced from a single animal.
    Wu TJ; Taylor RL; Kao PC
    Ann Clin Lab Sci; 1997; 27(5):384-90. PubMed ID: 9303178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic approach to hypercalcemia: relevance of parathyroid hormone and parathyroid hormone-related protein measurements.
    Casez J; Pfammatter R; Nguyen Q; Lippuner K; Jaeger P
    Eur J Intern Med; 2001 Jul; 12(4):344-349. PubMed ID: 11395297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay.
    Blind E; Schmidt-Gayk H; Scharla S; Flentje D; Fischer S; Göhring U; Hitzler W
    J Clin Endocrinol Metab; 1988 Aug; 67(2):353-60. PubMed ID: 3292561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.